Science & Innovation

Pipeline

Dorzagliatin

mGluR5

Poster and Presentation

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information (2552.HK)

Corporate Communications

Portfolio Advisory Board

Senior Scientific Advisory Board

Media

Media Releases

Jan 12

2018

China’s Hua Medicine seeks funding for US$200m diabetes drug development plan

Nov 08

2017

New Business in Action | Ep.2 New Drugs: Harvest Time is Coming

Apr 12

2017

Using Partnerships, Hua Medicine Brings Novel Diabetes Drug to Phase III

Dec 04

2016

The Chinese Dream on its Fourth Anniversary

Jul 20

2016

Sea turtles come back to China's biomedical industry

Apr 25

2016

Hua Medicine closes $50M round, looks to new diabetes target

Sep 20

2011

Hua Medicine Raises $50 Million to Develop and Commercialize Drugs

Sep 19

2011

Hua Medicine: A China Startup Led by Industry Veterans

About Us

Company Overview

Company History

Leadership Team

Portfolio Advisory Board

Senior Scientific Advisory Board

Partner

Media center

Research & Development

Inovation

Pipeline

Dorzagliatin

mGluR5

Company Publications

Peer Reviewed Publications

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Media

Company News

Media Releases

Video

Careers

Culture

Join Us

Product

HuaTangNing(華堂寧®)

Focus Us

滬公網(wǎng)安備 31011502013809號(hào) Privacy Statement Terms of Use

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.